NLRP3 and systemic sclerosis: The inflammasome, specifically the NLRP3-inflammasome, was shown to contribute SSc pathogenesis in vivo (30) through the induction of the microRNA miR-155, which in turn favors excessive ECM production by fibroblasts, exacerbating SSc (31).